Rare disease policies to improve care for patients in Europe

Biochimica Et Biophysica Acta
Charlotte Rodwell, Ségolène Aymé

Abstract

Rare diseases are those with a particularly low prevalence; in Europe, diseases are considered to be rare when they affect not more than 5 in 10000 persons in the European Union. The specificities of rare diseases make the area a veritable public health challenge: the limited number of patients and scarcity of knowledge and expertise single rare diseases out as a distinctive domain of high European added-value. The Orphan Medicinal Product Regulation of 1999 was the first European legislative text concerning rare diseases, followed by many initiatives, including recommendations by the Council of Ministers of the European Union in 2009. These initiatives contributed to the development of rare diseases policies at European and national level aimed at improving care for patients with rare diseases. A review of the political framework at European level and in European countries is provided to demonstrate how legislation has created a dynamic that is progressively improving care for patients with rare diseases. This article is part of a Special Issue entitled: "Current Research on the Neuronal Ceroid Lipofuscinoses (Batten Disease)".

Citations

Nov 6, 2015·Journal of Community Genetics·Sally Ann Lynch, Isabella Borg
Jun 24, 2017·Science China. Life Sciences·Jinmeng Jia, Tieliu Shi
Sep 19, 2019·European Journal of Human Genetics : EJHG·Stéphanie Nguengang WakapAna Rath
Dec 19, 2018·Intractable & Rare Diseases Research·Neil Khosla, Rodolfo Valdez
Sep 10, 2020·International Journal of Environmental Research and Public Health·Inmaculada C Palomo-ToucedoGabriel Domínguez-Maldonado
Sep 2, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·H A JinnahUNKNOWN International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders
Nov 7, 2018·Orphanet Journal of Rare Diseases·Márta SzegediMária Judit Molnár
Jul 1, 2020·Orphanet Journal of Rare Diseases·Dariusz Walkowiak, Jan Domaradzki
May 31, 2019·Orphanet Journal of Rare Diseases·Jean-Michel HeardUNKNOWN MetabERN collaboration group
Aug 9, 2020·Pharmaceutical Statistics·Konstantinos PaterasKit C B Roes
Nov 6, 2020·Orphanet Journal of Rare Diseases·Emer GunneSally Ann Lynch
Dec 6, 2020·International Journal of Environmental Research and Public Health·Isaac Aranda-ReneoJulio López-Bastida
Feb 19, 2021·Orphanet Journal of Rare Diseases·Nathalie M VandeveldeUNKNOWN Advisory Board of the Action 1 of the Belgian National Plan for Rare Diseases
Feb 20, 2021·Orphanet Journal of Rare Diseases·Thomas OpladenStefan Kölker
Apr 6, 2021·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·M DufossetB Chabrol
May 6, 2021·Journal of Community Genetics·Victoria HedleyDomenica Taruscio
Jun 30, 2021·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Angela A Navarrete-OpazoSheldon R Garrison
Jun 15, 2021·Frontiers in Genetics·Jan Domaradzki, Dariusz Walkowiak
Jun 28, 2021·Current Opinion in Oncology·Christianne Lok, Frédéric Amant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.

Related Papers

Advances in Experimental Medicine and Biology
Antoni Montserrat Moliner
Public Health Genomics
A Montserrat Moliner, J Waligóra
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
Sara E Mole
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
Sara E Mole
© 2022 Meta ULC. All rights reserved